当前位置： SCI文献检索 > BMC Pulmonary Medicine期刊下所有文献 > Novel biomarker genes which distinguish between smokers and chronic obstructive pulmonary disease patients with machine learning approach.

Novel biomarker genes which distinguish between smokers and chronic obstructive pulmonary disease patients with machine learning approach.

Abstract：

BACKGROUND:Chronic obstructive pulmonary disease (COPD) is combination of progressive lung diseases. The diagnosis of COPD is generally based on the pulmonary function testing, however, difficulties underlie in prognosis of smokers or early stage of COPD patients due to the complexity and heterogeneity of the pathogenesis. Computational analyses of omics technologies are expected as one of the solutions to resolve such complexities. METHODS:We obtained transcriptomic data by in vitro testing with exposures of human bronchial epithelial cells to the inducers for early events of COPD to identify the potential descriptive marker genes. With the identified genes, the machine learning technique was employed with the publicly available transcriptome data obtained from the lung specimens of COPD and non-COPD patients to develop the model that can reflect the risk continuum across smoking and COPD. RESULTS:The expression levels of 15 genes were commonly altered among in vitro tissues exposed to known inducible factors for earlier events of COPD (exposure to cigarette smoke, DNA damage, oxidative stress, and inflammation), and 10 of these genes and their corresponding proteins have not previously reported as COPD biomarkers. Although these genes were able to predict each group with 65% accuracy, the accuracy with which they were able to discriminate COPD subjects from smokers was only 29%. Furthermore, logistic regression enabled the conversion of gene expression levels to a numerical index, which we named the "potential risk factor (PRF)" index. The highest significant index value was recorded in COPD subjects (0.56 at the median), followed by smokers (0.30) and non-smokers (0.02). In vitro tissues exposed to cigarette smoke displayed dose-dependent increases of PRF, suggesting its utility for prospective risk estimation of tobacco products. CONCLUSIONS:Our experimental-based transcriptomic analysis identified novel genes associated with COPD, and the 15 genes could distinguish smokers and COPD subjects from non-smokers via machine-learning classification with remarkable accuracy. We also suggested a PRF index that can quantitatively reflect the risk continuum across smoking and COPD pathogenesis, and we believe it will provide an improved understanding of smoking effects and new insights into COPD.

journal_name

BMC Pulm Med

journal_title

BMC pulmonary medicine

authors

Matsumura K,Ito S

doi

10.1186/s12890-020-1062-9

subject

Has Abstract

pub_date

2020-02-03 00:00:00

pages

issue

issn

1471-2466

pii

10.1186/s12890-020-1062-9

journal_volume

pub_type

杂志文章

在线工具

Novel biomarker genes which distinguish between smokers and chronic obstructive pulmonary disease patients with machine learning approach.